Lupin Ltd. (NSE: LUPIN) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Ramesh Swaminathan -- Executive Director, Global CFO and Head Nilesh
Lupin Ltd. (LUPIN) Q4 FY22 Earnings Concall Transcript
Categories
pharmaceuticals
Cipla Ltd. (CIPLA) Q4 FY22 Earnings Concall Transcript
Cipla Ltd. (NSE: CIPLA) Q4 FY22 Earnings Concall dated May. 10, 2022 Corporate Participants: Naveen Bansal -- Head Investor Relations Umang Vohra -- Managing Director And
Neuland Laboratories Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/SoKfArytP_s Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q4 FY22 Earnings Concall Management Update: NEULANDLAB said its capex plan is on track
Cipla Limited Q4 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=I-Ubq3MAmzg Key highlights from Cipla Limited (CIPLA) Q4 FY22 Earnings Concall Management Update: CIPLA said it crossed the $1 billion milestone in
Biocon Limited (BIOCON) Q4 2022 Earnings Concall Transcript
Biocon Limited (NSE: BIOCON) Q4 2022 earnings concall dated Apr. 29, 2022 Corporate Participants: Aishwarya Seetharam -- Head, Investor Relations Kiran Mazumdar Shaw -- Executive Chairperson
Glenmark Life Sciences Limited Q4 FY22 Earnings Conference Call Summary
https://youtu.be/au71QUL41tY Key highlights from Glenmark Life Sciences Limited (GLS) Q4 FY22 Earnings Concall Q&A Highlights: Neha Manpuria of Bank of America asked
Infographic: All you need to know about Apollo Hospital Q3 results
Apollo Hospitals(NSE:APOLLOHOSP) reported its third-quarter 2022 earnings results. The hospital chain had a consolidated revenue of ₹3,656 crores with a growth of
Sun Pharma Research Tear Sheet Q3 FY 2022
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company. The company was incorporated in 1983. It has its headquarter in Mumbai, Maharashtra India. The company
Aurobindo Pharma Q3 FY 2022 Research Tear Sheet
Aurobindo Pharma Limited is an Indian pharmaceutical company. It is based in HITEC City, Hyderabad, India. It was incorporated in 1986. The pharmaceutical products include
Dr. Reddy’s Laboratories Q3 FY 2022 Research Tear Sheet
Dr. Reddy's Laboratories are an Indian multinational pharmaceutical company. The company is headquartered in Hyderabad, Telangana, India and Princeton, New Jersey, U.S. It was incorporated in
Solara Active Pharma Sciences Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/mZLf2s4bnQ8 Key highlights from Solara Active Pharma Sciences Limited (SOLARA) Q3 FY22 Earnings Concall Q&A Highlights: Kunal Randeria from Edelweiss asked about
Gufic Biosciences Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/f3tlyxhD91U Key highlights from Gufic Biosciences Limited (GUFICBIO) Q3 FY22 Earnings Concall Management Update: In CDMO, GUFICBIO said it’s looking at a
Sanofi India Ltd Q4 CY21 Earnings Conference Call Insights
https://youtu.be/D2vfw6hB5RI Key highlights from Sanofi India Ltd (SANOFI) Q4 CY21 Earnings Concall Q&A Highlights: Vipul Shah of RippleWave Equity asked if the
Sanofi India Ltd (SANOFI) Q4 FY21 Earnings Concall
Sanofi India Ltd (NSE:SANOFI) Q4 FY21 Earnings Concall dated Mar. 02, 2022
Hikal Limited Q3 FY22 Earnings Conference Call Insights
Key highlights from Hikal Limited (HIKAL) Q3 FY22 Earnings Concall Management Update: HIKAL stated that the company expects some short term impact
Orchid Pharma Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=z2DK9xz1c8k Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY22 Earnings Concall Q&A Highlights: Viraj Kacharia from Securities Investment asked about the
JB Chemicals & Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=HiVTF6vv9q0 Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY22 Earnings Concall Management Update: The company outperformed the sector with
NATCO Pharma Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=bt9cDow2-2c Key highlights from NATCO Pharma Limited (NATCOPHARM) Q3 FY22 Earnings Concall Q&A Highlights: Tarang Agrawal from Old Bridge asked about the
Glenmark Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=Mzpw87FqOBE Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY22 Earnings Concall Management Update: GLENMARK stated the India business continues to outperform
Sequent Scientific Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=iqM668J91yY Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY22 Earnings Concall Management Update: SEQUENT saw significant improvement in the API order
Divi’s Laboratories Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=E7EoiAKzMn0 Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Concall Management Update: The company capitalized INR196 crores in 3Q22 and